Clinical Trial: Multimodal Thermal Therapy Combined With Targeted Therapy and Immunotherapy Versus Targeted Therapy and Immunotherapy Alone for Systemically Untreated Unresectable Hepatocellular Carcinoma (HCC).

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596134) titled 'Multimodal Thermal Therapy Combined With Targeted Therapy and Immunotherapy Versus Targeted Therapy and Immunotherapy Alone for Systemically Untreated Unresectable Hepatocellular Carcinoma (HCC).' on May 02.

Brief Summary: Multimodal Thermal Therapy combined with targeted therapy and immunotherapy versus targeted therapy and immunotherapy alone for systemically untreated unresectable hepatocellular carcinoma (HCC)

Study Start Date: May 25

Study Type: INTERVENTIONAL

Condition: Unresectable Hepatocellular Carcinoma (HCC)

Intervention: DEVICE: Multimodal Thermal Therapy

Multimodal Thermal Therapy (MTT) is an advanced ablation tec...